View in EDS PDF Full Text

Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials.

Saved in:
Bibliographic Details
Title: Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials.
Authors: Janes H; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Fisher LH; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Kee JJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Parameswaran L; New York University Langone Vaccine Center, New York University Grossman School of Medicine, New York, New York, USA., Goepfert PA; Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Falsey AR; Infectious Disease Division, University of Rochester, Rochester, New York, USA., Ludwig J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Magaret CA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Rouphael N; Hope Clinic, Emory University, Atlanta, Georgia, USA., Sobieszczyk ME; Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA., El Sahly HM; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA., Baden LR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA., Grinsztejn B; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil., Walsh SR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA., Gray GE; South African Medical Research Council, Cape Town, South Africa., Kotloff KL; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA., Gay CL; Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Greninger AL; Department of Medicine, Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington, USA., Tapia MD; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA., Hammershaimb EA; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA., Priddy FH; Moderna, Inc, Cambridge, Massachusetts, USA., Green JA; Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, United Kingdom., Struyf F; Janssen Research and Development, Beerse, Belgium., Dunkle L; Novavax, Inc, Gaithersburg, Maryland, USA., Neuzil KM; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Source: The Journal of infectious diseases [J Infect Dis] 2024 Dec 16; Vol. 230 (6), pp. 1384-1389.
Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39225478
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Janes+H%22">Janes H</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Fisher+LH%22">Fisher LH</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Kee+JJ%22">Kee JJ</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Parameswaran+L%22">Parameswaran L</searchLink>; New York University Langone Vaccine Center, New York University Grossman School of Medicine, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Goepfert+PA%22">Goepfert PA</searchLink>; Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.<br /><searchLink fieldCode="AU" term="%22Falsey+AR%22">Falsey AR</searchLink>; Infectious Disease Division, University of Rochester, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Ludwig+J%22">Ludwig J</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Magaret+CA%22">Magaret CA</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Gilbert+PB%22">Gilbert PB</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Kublin+JG%22">Kublin JG</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Rouphael+N%22">Rouphael N</searchLink>; Hope Clinic, Emory University, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Sobieszczyk+ME%22">Sobieszczyk ME</searchLink>; Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22El+Sahly+HM%22">El Sahly HM</searchLink>; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Baden+LR%22">Baden LR</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Grinsztejn+B%22">Grinsztejn B</searchLink>; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.<br /><searchLink fieldCode="AU" term="%22Walsh+SR%22">Walsh SR</searchLink>; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Gray+GE%22">Gray GE</searchLink>; South African Medical Research Council, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Kotloff+KL%22">Kotloff KL</searchLink>; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Gay+CL%22">Gay CL</searchLink>; Division of Infectious Diseases, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Greninger+AL%22">Greninger AL</searchLink>; Department of Medicine, Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Tapia+MD%22">Tapia MD</searchLink>; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Hammershaimb+EA%22">Hammershaimb EA</searchLink>; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Priddy+FH%22">Priddy FH</searchLink>; Moderna, Inc, Cambridge, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Green+JA%22">Green JA</searchLink>; Vaccines and Immune Therapies, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Struyf+F%22">Struyf F</searchLink>; Janssen Research and Development, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Dunkle+L%22">Dunkle L</searchLink>; Novavax, Inc, Gaithersburg, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Neuzil+KM%22">Neuzil KM</searchLink>; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Corey+L%22">Corey L</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Huang+Y%22">Huang Y</searchLink>; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2024 Dec 16; Vol. 230 (6), pp. 1384-1389.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39225478
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/infdis/jiae400
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1384
    Titles:
      – TitleFull: Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Janes H
      – PersonEntity:
          Name:
            NameFull: Fisher LH
      – PersonEntity:
          Name:
            NameFull: Kee JJ
      – PersonEntity:
          Name:
            NameFull: Parameswaran L
      – PersonEntity:
          Name:
            NameFull: Goepfert PA
      – PersonEntity:
          Name:
            NameFull: Falsey AR
      – PersonEntity:
          Name:
            NameFull: Ludwig J
      – PersonEntity:
          Name:
            NameFull: Magaret CA
      – PersonEntity:
          Name:
            NameFull: Gilbert PB
      – PersonEntity:
          Name:
            NameFull: Kublin JG
      – PersonEntity:
          Name:
            NameFull: Rouphael N
      – PersonEntity:
          Name:
            NameFull: Sobieszczyk ME
      – PersonEntity:
          Name:
            NameFull: El Sahly HM
      – PersonEntity:
          Name:
            NameFull: Baden LR
      – PersonEntity:
          Name:
            NameFull: Grinsztejn B
      – PersonEntity:
          Name:
            NameFull: Walsh SR
      – PersonEntity:
          Name:
            NameFull: Gray GE
      – PersonEntity:
          Name:
            NameFull: Kotloff KL
      – PersonEntity:
          Name:
            NameFull: Gay CL
      – PersonEntity:
          Name:
            NameFull: Greninger AL
      – PersonEntity:
          Name:
            NameFull: Tapia MD
      – PersonEntity:
          Name:
            NameFull: Hammershaimb EA
      – PersonEntity:
          Name:
            NameFull: Priddy FH
      – PersonEntity:
          Name:
            NameFull: Green JA
      – PersonEntity:
          Name:
            NameFull: Struyf F
      – PersonEntity:
          Name:
            NameFull: Dunkle L
      – PersonEntity:
          Name:
            NameFull: Neuzil KM
      – PersonEntity:
          Name:
            NameFull: Corey L
      – PersonEntity:
          Name:
            NameFull: Huang Y
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 12
              Text: 2024 Dec 16
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6613
          Numbering:
            – Type: volume
              Value: 230
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: The Journal of infectious diseases
              Type: main
ResultId 1